Seegene Stock Number Of Employees
| 096530 Stock | KRW 23,150 50.00 0.22% |
Seegene fundamentals help investors to digest information that contributes to Seegene's financial success or failures. It also enables traders to predict the movement of Seegene Stock. The fundamental analysis module provides a way to measure Seegene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Seegene stock.
Seegene |
Seegene Company Number Of Employees Analysis
Seegene's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Seegene Number Of Employees | 1.01 K |
Most of Seegene's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Seegene is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, Seegene is currently employing 1.01 K people. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The number of employees for all Republic of Korea stocks is notably lower than that of the firm.
Seegene is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 1,585. Seegene totals roughly 1,008 in number of employees claiming about 64% of equities under Health Care industry.Seegene Fundamentals
| Return On Equity | 0.32 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 0.32 % | |||
| Current Valuation | 3.51 T | |||
| Shares Outstanding | 25.99 M | |||
| Shares Owned By Insiders | 30.90 % | |||
| Shares Owned By Institutions | 9.23 % | |||
| Price To Earning | 140.12 X | |||
| Price To Sales | 0.65 X | |||
| Revenue | 1.37 T | |||
| Gross Profit | 1 T | |||
| EBITDA | 415.89 B | |||
| Net Income | 536.56 B | |||
| Cash And Equivalents | 432.13 B | |||
| Total Debt | 102.81 B | |||
| Debt To Equity | 8.90 % | |||
| Current Ratio | 4.91 X | |||
| Cash Flow From Operations | 334.02 B | |||
| Target Price | 52050.0 | |||
| Number Of Employees | 1.01 K | |||
| Beta | -0.97 | |||
| Market Capitalization | 700.48 B | |||
| Total Asset | 1.49 T | |||
| Retained Earnings | 46.11 B | |||
| Working Capital | 139.97 B | |||
| Current Asset | 151.8 B | |||
| Current Liabilities | 11.83 B | |||
| Z Score | 3.6 | |||
| Annual Yield | 0 % | |||
| Net Asset | 1.49 T |
About Seegene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Seegene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Seegene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Seegene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Seegene Stock
Seegene financial ratios help investors to determine whether Seegene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seegene with respect to the benefits of owning Seegene security.